Type(s) of Cancer
Breast
Breast
Study Phase
Phase 2BPhase 3
Study Completion Date
March 2013
March 2013
NCT00703326Uploaded 01-05-2017
Available for Download
PDS UID: Breast_EliLill_2008_168
A Multicenter, Multinational, Randomized, Double-Blind, Phase III Study of IMC-1121B Plus Docetaxel Versus Placebo Plus Docetaxel in Previously Untreated Patients With HER2-Negative, Unresectable, Locally-Recurrent or Metastatic Breast Cancer
Files:
PROTOCOLV8.0 Protocol CP12-0606_Redacted.pdf
CRFJVBC_SDTM_aCRF_redacted.pdf
DATA DICTIONARYJVBC_ADaM_dataset_specifications_redacted.pdf
DATA (COMPARATOR ARM)adam20161103.zip